This report describes the challenges in West Africa and the policies the region must adopt to prevent drug trafficking, production and consumption from undermining states and societies, and destroying lives.
The report highlights the failures related to the international scheduling of controlled drugs, and proposes key recommendations to ensure a system based on health and evidence.
This briefing clarifies the extent of Portugal’s achievement, and debunks some of the erroneous claims made about the country’s innovative approach to drugs.
The EU needs to improve its knowledge of drug markets and criminal activities in beneficiary countries, to ensure their projects are sensitive to the potentially counterproductive effects on organised crime and the drug trade in West Africa.
This study aims to estimate the number of people with chronic HCV infection in England that are treated and assess the impact and costs of increasing treatment uptake.
On 19 - 20 May, 2014 a high level Regional Forum on healthcare and human rights of people who use drugs took place in Chisinau (Moldova) under the auspice of Eurasian Harm Reduction Network (EHRN).
To get the life-saving drug naloxone to people at risk of overdose from prescription painkillers, US states are adopting decade-old tactics pioneered in heroin users in New Mexico.
185 million people across the world are infected with HCV; 150 million are chronically infected. This analysis tries to determine whether the strategies employed by pharmaceutical companies would be good for access.
This paper examines the impact of Canada's war on drugs on segments of the black community, specifically with respect to the impact of structural violence, over-policing, and high incarceration rates
The discussions focused on two key issues: a) current impacts, trends, and challenges related to retail drug distribution; and b) new responses to local markets for illegal drugs.
